British Journal of Anaesthesia, Vol 84, Issue 1 97-99, Copyright © 2000 by Oxford University Press
TM Buetler, OH Wilder-Smith, CH Wilder-Smith, S Aebi, T Cerny and R Brenneisen
The pharmacodynamics of morphine-6-glucuronide (M-6-G) i.v. were assessed
in 12 healthy male volunteers in an open study. After a single bolus dose
of M-6-G 5 mg i.v., we measured antinociceptive effects, using electrical
and cold pain tests, and plasma concentrations of M-6- G,
morphine-3-glucuronide (M-3-G) and morphine. Pain intensities during
electrical stimulation (at 30, 60 and 90 min after injection) and ice water
immersion (at 60 min) decreased significantly (P < 0.005) compared with
baseline. Mean plasma peak concentrations of M-6-G were 139.3 (SD 38.9) ng
ml-1, measured at 15 min. Our data demonstrate that M-6-G has significant
analgesic activity.
ARTICLES
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers
Department of Clinical Research, University of Bern, Switzerland.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. L. A. van Dorp, R. Romberg, E. Sarton, J. G. Bovill, and A. Dahan Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief? Anesth. Analg., June 1, 2006; 102(6): 1789 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Armstrong and K. L. Cozza Pharmacokinetic Drug Interactions of Morphine, Codeine, and Their Derivatives: Theory and Clinical Reality, Part I Psychosomatics, April 1, 2003; 44(2): 167 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oellerich and V. W. Armstrong Prodrug Metabolites: Implications for Therapeutic Drug Monitoring Clin. Chem., May 1, 2001; 47(5): 805 - 806. [Full Text] [PDF] |
||||


